Cargando…
Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial
To determine the morbidity, mortality, and pathologic outcomes of transanal total mesorectal resection (taTME) versus laparoscopic total mesorectal excision (laTME) among patients with rectal cancer with clinical stage I to III rectal cancer below the peritoneal reflection. BACKGROUND: Studies with...
Autores principales: | Liu, Huashan, Zeng, Ziwei, Zhang, Hong, Wu, Miao, Ma, Dan, Wang, Quan, Xie, Ming, Xu, Qing, Ouyang, Jun, Xiao, Yi, Song, Yongchun, Feng, Bo, Xu, Qingwen, Wang, Yanan, Zhang, Yi, Hao, Yuantao, Luo, Shuangling, Zhang, Xingwei, Yang, Zuli, Peng, Junsheng, Wu, Xiaojian, Ren, Donglin, Huang, Meijin, Lan, Ping, Tong, Weidong, Ren, Mingyang, Wang, Jianping, Kang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762710/ https://www.ncbi.nlm.nih.gov/pubmed/35815886 http://dx.doi.org/10.1097/SLA.0000000000005523 |
Ejemplares similares
-
Transanal vs laparoscopic total mesorectal excision for rectal cancer: a multicenter randomized phase III clinical trial (TaLaR trial) protocol
por: Kang, Liang, et al.
Publicado: (2020) -
Structured training curriculums for transanal total mesorectal excision in China: refinement is needed
por: Xu, Ximo, et al.
Publicado: (2022) -
Clinical Status and Future Prospects of Transanal Total Mesorectal Excision
por: Guo, Zichao, et al.
Publicado: (2022) -
Transanal versus Laparoscopic Total Mesorectal Excision in Male Patients with Low Tumor Location after Neoadjuvant Therapy: A Propensity Score-Matched Cohort Study
por: Li, Ze, et al.
Publicado: (2022) -
Short- and mid-term outcomes of transanal versus laparoscopic total mesorectal excision for low rectal cancer: a meta-analysis
por: Ren, Jingqing, et al.
Publicado: (2021)